ICR
Caroline was most recently a Managing Director in equity research at Cantor Fitzgerald covering medical technology. She previously held senior research positions at MLV & Co., Pacific Growth Equities and Wells Fargo Securities, covering medical devices and diagnostics and has also worked heading investor relations within a publicly-traded life science company. Caroline has participated in numerous IPOs and capital raises for small- to mid-cap companies. Prior to entering equity research, she held engineering and product development positions at Baxter Transfusion Therapies and Eli Lilly and Company. Caroline received her Ph.D. in Biological Engineering from Cornell University and a BS in Biological Systems Engineering from Virginia Tech.
This person is not in any teams
This person is not in any offices
ICR
1 followers
ICR partners with companies to develop and execute strategic communications programs that achieve business goals, build credibility, and enhance the long-term value of the enterprise. The firm’s highly differentiated service model, which pairs capital markets veterans with senior communications professionals, brings deep sector knowledge and relationships to clients in more than 20 industries. Today, ICR is one of the largest and most experienced independent advisory firms in North America maintaining offices in Boston, Connecticut, Los Angeles, New York, San Francisco, Beijing and Hong Kong.